CDK4 inhibition restores G₁-S arrest inMYCN-amplified neuroblastoma cells in the context of doxorubicin-induced DNA damage
出版年份 2013 全文链接
标题
CDK4 inhibition restores G₁-S arrest inMYCN-amplified neuroblastoma cells in the context of doxorubicin-induced DNA damage
作者
关键词
-
出版物
CELL CYCLE
Volume 12, Issue 7, Pages 1091-1104
出版商
Informa UK Limited
发表日期
2013-03-29
DOI
10.4161/cc.24091
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A chemical screen identifies the chemotherapeutic drug topotecan as a specific inhibitor of the B-MYB/MYCN axis in neuroblastoma.
- (2015) Francesco Sottile et al. Oncotarget
- Mantle cell lymphoma-like lymphomas in c-myc-3’RR/p53+/- mice and c-myc-3’RR/Cdk4R24C mice: differential oncogenic mechanisms but similar cellular origin
- (2015) Pauline Rouaud et al. Oncotarget
- Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma
- (2012) J. P. Leonard et al. BLOOD
- Genomic rearrangements at the FRA2H common fragile site frequently involve non-homologous recombination events across LTR and L1(LINE) repeats
- (2012) Lena M. Brueckner et al. HUMAN GENETICS
- Multiple Roles of Cyclin-Dependent Kinase 4/6 Inhibitors in Cancer Therapy
- (2012) Patrick J. Roberts et al. JNCI-Journal of the National Cancer Institute
- Chemical Genetics Reveals a Specific Requirement for Cdk2 Activity in the DNA Damage Response and Identifies Nbs1 as a Cdk2 Substrate in Human Cells
- (2012) Lara Wohlbold et al. PLoS Genetics
- Phase I study of PD 0332991, a cyclin-dependent kinase inhibitor, administered in 3-week cycles (Schedule 2/1)
- (2011) G K Schwartz et al. BRITISH JOURNAL OF CANCER
- CAMTA1, a 1p36 Tumor Suppressor Candidate, Inhibits Growth and Activates Differentiation Programs in Neuroblastoma Cells
- (2011) K.-O. Henrich et al. CANCER RESEARCH
- Outcome of the p53-mediated DNA damage response in neuroblastoma is determined by morphological subtype and MYCN expression
- (2011) Jane Carr-Wilkinson et al. CELL CYCLE
- Crosstalk between MYCN and MDM2-p53 signal pathways regulates tumor cell growth and apoptosis in neuroblastoma
- (2011) Jing He et al. CELL CYCLE
- MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival
- (2011) E A Afanasyeva et al. CELL DEATH AND DIFFERENTIATION
- Phase I, Dose-Escalation Trial of the Oral Cyclin-Dependent Kinase 4/6 Inhibitor PD 0332991, Administered Using a 21-Day Schedule in Patients with Advanced Cancer
- (2011) K. T. Flaherty et al. CLINICAL CANCER RESEARCH
- Expression of p16 and Retinoblastoma Determines Response to CDK4/6 Inhibition in Ovarian Cancer
- (2011) Gottfried E. Konecny et al. CLINICAL CANCER RESEARCH
- MYCN/MYC-mediated drug resistance mechanisms in neuroblastoma
- (2011) S. Gogolin et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- MYCN oncoprotein targets and their therapeutic potential
- (2010) Emma Bell et al. CANCER LETTERS
- Transcriptional Repression of SKP2 Is Impaired in MYCN-Amplified Neuroblastoma
- (2010) Daniel Muth et al. CANCER RESEARCH
- p53 Is a Direct Transcriptional Target of MYCN in Neuroblastoma
- (2010) L. Chen et al. CANCER RESEARCH
- Pharmacologic Inhibition of Cyclin-Dependent Kinases 4 and 6 Arrests the Growth of Glioblastoma Multiforme Intracranial Xenografts
- (2010) K. Michaud et al. CANCER RESEARCH
- High Frequency of p53/MDM2/p14ARF Pathway Abnormalities in Relapsed Neuroblastoma
- (2010) J. Carr-Wilkinson et al. CLINICAL CANCER RESEARCH
- Mitigation of hematologic radiation toxicity in mice through pharmacological quiescence induced by CDK4/6 inhibition
- (2010) Søren M. Johnson et al. JOURNAL OF CLINICAL INVESTIGATION
- Regulation of BIRC5 and its isoform BIRC5-2B in neuroblastoma
- (2009) Isabella Eckerle et al. CANCER LETTERS
- Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells
- (2009) J. J. Molenaar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- p73α isoforms drive opposite transcriptional and post-transcriptional regulation of MYCN expression in neuroblastoma cells
- (2008) Emilie Horvilleur et al. NUCLEIC ACIDS RESEARCH
- Outcomes of the POG 9340/9341/9342 trials for children with high-risk neuroblastoma: A report from the Children's Oncology Group
- (2008) Peter E. Zage et al. PEDIATRIC BLOOD & CANCER
- Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas
- (2008) Frank Westermann et al. GENOME BIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started